Speaker
Description
In the world today it is more clear than ever the importance of accelerating the process of the production of vaccines as well as making it a commodity for the whole world.
This project aims to validate a model that can be used to predict the performance of a novel vaccine candidate, more specifically a bacterial vaccine candidate by using molecular dynamics simulations, reducing costs and time. This type of vaccine is our best solution to solve the problem of antimicrobial resistance due to the widespread use of antibiotics over the last years.
It will be performed in collaboration with the Bacterial Vaccines Department of Johnson & Johnson and connects the fields of physics and biology by applying known physical models and equations to biological compounds like proteins.
